Search clinical trials for: Smallpox Vaccine

Total 9996 results

Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

Atopic Dermatitis

United States, Mexico
Bavarian Nordic

Completed

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

Smallpox

United States
Bavarian Nordic
National Institutes of Health (NIH)

Completed

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

HIV Infections

United States, Puerto Rico
National Eye Institute (NEI)

Completed

Evaluation and Treatment of Eye Complications of Vaccinia Vaccination

Vaccinia

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

SIGA-246 to Treat Smallpox

Vaccinia

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

ACAM 3000 MVA at Harvard Medical School

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Combination Study With MVA BN and Dryvax

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

Smallpox

United States
Sanofi Pasteur, a Sanofi Company

Terminated

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

HIV Infections | Smallpox

United States
Sanofi Pasteur, a Sanofi Company

Withdrawn

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Atopic Dermatitis | Smallpox

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine

Smallpox
Sanofi Pasteur, a Sanofi Company

Terminated

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Smallpox

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Smallpox

United States
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers

Smallpox

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

MVA Post-Event: Administration Timing and Boost Study

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects

Variola Major (Smallpox)

United States
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Efficacy of CJ-50300 in Healthy Volunteers

Smallpox

Korea, Republic of
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers

Smallpox

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Variola Major (Smallpox)

United States
Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients

HIV Infections

United States
Sanofi

Completed

A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)

Smallpox

France
Sanofi

Completed

Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

Smallpox | Poxvirus Infection

France
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

APSV in Vaccinia Naive Adults

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Smallpox Vaccine

Healthy

United States
Bristol-Myers Squibb

Completed

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

HIV Infections

United States
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Immunogenicity of CJ-50300

Smallpox

Korea, Republic of
VaxGen

Unknown

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

Smallpox

United States
Bavarian Nordic

Completed

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Smallpox

Germany
Bavarian Nordic

Completed

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

Smallpox

Germany
Pfizer

Not yet recruiting

SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

Respiratory Tract Infection

Japan
Novavax

Not yet recruiting

Phase 3 Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

COVID-19
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Not yet recruiting

Correlation of Protection Against Varicella in an Exploratory Study

Varicella
Johns Hopkins Bloomberg School of Public Health
Emory University; Children's Healthcare of Atlanta

Not yet recruiting

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

Vaccine Hesitancy | Vaccine Refusal

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Solid Tumor, Adult | DC

China
Pfizer

Not yet recruiting

A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults. (Amélie)

Respiratory Syncytial Virus (RSV)

United States
OSE Immunotherapeutics
Exystat; Genome Diagnostics (GenDx)

Not yet recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor (ARTEMIA)

Patients With Non-Small Cell Lung Cancer

United States
Sinovac Life Sciences Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of PCV24 in Adults

Pneumococcal Infectious Disease

China
University of Michigan
African Population and Health Research Center

Not yet recruiting

The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa

Vaccines

Kenya, Uganda
Shanghai Bovax Biotechnology Co., Ltd.

Not yet recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Anal Cancer | HPV-Related Carcinoma | Penile Cancer | Genital Wart | AIN3 | AIN2 | PIN-1 | AIN1 | PIN2 | PIN3

China
Genelux Corporation
Newsoara Biopharma Co., Ltd.

Not yet recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's of Choice Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (VIRO-25) ((VIRO-25))

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Advanced Non-squamous Non-small-cell Lung Cancer | Non-small Cell Lung Cancer Stage IV | Metastatic Squamous Non-Small Cell Lung Carcinoma | Non-small Cell Lung Cancer Recurrent | Metastatic Non-squamous Non Small Cell Lung Cancer and other conditions
InventVacc Biologicals Inc.
Hia Consortium

Recruiting

A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine

Haemophilus Influenzae Meningitis | Invasive Haemophilus Influenzae Disease

Canada
Laure Pittet, MD-PhD

Recruiting

Registry of Vaccine Responses in Immune Compromised Patients (REVAPI)

Immunosuppression

Switzerland
Sumitomo Pharma Co., Ltd.

Not yet recruiting

First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP

Influenza

Belgium
Massachusetts General Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh

Not yet recruiting

Correlates of Protection for Cholera (CoP)

Cholera
Shanghai Bovax Biotechnology Co., Ltd.

Not yet recruiting

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

HPV Infection | HPV-Related Carcinoma | Genital Wart | HPV-Related Intraepithelial Neoplasia

China

Search clinical trials for: Smallpox Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations